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Abstract

Background: Postoperative nausea and vomiting (PONV) is known to occur after bariatric surgery,
with over two thirds of patients affected. However, variability exists in how to objectively measure
PONV.
Objectives: The goals of the present study were to use a validated, patient-centered scoring tool, the
Rhodes Index of Nausea, Vomiting, and Retching to measure the severity of PONVafter bariatric surgery, to directly compare PONV between patients who underwent laparoscopic sleeve gastrectomy
(LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB), and to identify risk factors for the
development of PONV after bariatric surgery.
Setting: Barnes-Jewish Hospital/Washington University School of Medicine, St. Louis, Missouri,
United States of America.
Methods: The Washington University Weight Loss Surgery team prospectively surveyed patients
from January 1, 2017 to December 1, 2018 at the following 6 different timepoints: postoperative
day (POD) 0, POD 1, POD 2, POD 3 to 4, the first postoperative outpatient visit (POV 1: POD
5–25), and the second postoperative visit (POV 2: POD 25–50). At each timepoint, a cumulative
Rhodes score was calculated from the sum of 8 questions. The American Society for Metabolic
and Bariatric Surgery Accreditation and Quality Improvement Program database was used to collect
patient demographic characteristics and perioperative clinical data.
Results: A total of 274 patients met study criteria and completed 605 Rhodes questionnaires. Two
hundred fifty Rhodes questionnaires were completed by patients after SG and 355 were completed
by patients after LRYGB. Total Rhodes scores are statistically higher in LSG patients compared
with patients who underwent LRYGB (LSG 5 5.45 6 6.27; LRYGB 5 3.08 6 4.19, P 5 .0002).
Additionally, at the earlier timepoints, scores were higher among patients who underwent LSG
than those who had undergone LRYGB as follows: POD 0 (LSG 5 6.96 6 6.50; LRYGB 5 2.89
6 2.90, P 5 .0115), POD 1 (LSG 5 8.20 6 6.76; LRYGB 5 2.88 6 3.44, P , .0001), and POD
2 (LSG 5 4.05 6 4.88; LRYGB 5 2.06 6 3.43, P 5 .05). On subset analysis, examining patients
who either underwent an LSG or LRYGB, both procedures had a statistically significant PONV
peak emerge on POV 2. Last, overall Rhodes scores were statistically higher in female patients
compared with male patients (female: 4.43 6 5.46; male: 2.35 6 3.90, P 5 .021). Although the
magnitude of the difference varied somewhat across POD time intervals, the difference was most
pronounced at POV 2.

* Correspondence: Bradley Kushner, M.D., Section of Minimally Invasive
Surgery, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8109, Saint Louis, MO 63110.

E-mail address: b.kushner@wustl.edu (B.S. Kushner).

https://doi.org/10.1016/j.soard.2020.05.017
1550-7289/Ó 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusions: This is the largest study using a validated nausea and vomiting questionnaire to objectively measure PONV after bariatric surgery. The factors found to be most associated with increased
PONV were LSG and female sex. Ultimately, these data can help bariatric surgery programs,
including Washington University Weight Loss Surgery, identify patients who may require more
intensive treatment of PONV, particularly POD 0 to 2, and help to identify patients that continue
to struggle with PONV in the later surgical recovery phase. (Surg Obes Relat Dis 2020;16:1505–
1513.) Ó 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Key words:

Postoperative nausea and vomiting; Obesity surgery; Laparoscopic sleeve gastrectomy; Roux-en-Y gastric
bypass; Rhodes Index of Nausea; Vomiting; and Retching

The disease of obesity is a major public health issue [1],
and bariatric surgery is its effective treatment [2]. Laparoscopic sleeve gastrectomy (LSG) and laparoscopic Rouxen-Y gastric bypass (LRYGB) are the 2 most commonly
performed bariatric procedures today. While complication
rates are low, postoperative nausea and vomiting (PONV)
is a well-known complication after bariatric surgery, with
over two thirds of patients affected [3]. Additionally,
PONV leading to dehydration is the most common reason
for readmission after bariatric surgery [4]. Despite the prevalence of PONV after bariatric surgery, only a few studies
have previously compared the severity of nausea between
the 2 most common bariatric surgical procedures, LSG
and LRYGB.
Objectively measuring nausea and vomiting remains challenging, and significant variability exists in how to accurately
measure PONV [3]. A number of grading and scoring tools
exist to measure nausea and vomiting, such as the Functional
Living Index-Emesis [5]. Still, others have studied PONV
through the use of questions that yield dichotomous data in
the form of yes or no answers. For example, “Are you nauseated?” or “Did you vomit [6]?” These techniques are effective
at classifying patients as asymptomatic or symptomatic, but
they do not adequately reflect the presence or the range of
symptoms or the true scope of upper gastrointestinal discomfort [6]. While group data are appropriate for reporting the
epidemiologic features of the symptoms, they are not sensitive in measuring individual change or evaluating the effectiveness of interventions [6]. Moreover, nausea, vomiting,
and retching can all occur on their own and should be
addressed independently [7].
The problem of measuring PONV is further complicated
when one considers a clinician’s perspective and preferences may differ from that of the patients. Nausea is a subjective symptom and should be evaluated by the patient and
not the observer [7]. Therefore, a patient-centered scoring
system, where a patient’s perception, rather than the clinician’s observations, are used for symptom recognition is
important. Patients are more likely to prioritize their comfort and quality of recovery after surgery compared with clinicians, who may be more likely to report other serious

complications that can stem from PONV rather than the
severity of nausea alone [8]. Furthermore, clinical tools
that facilitate the involvement of patients enhance
provider-patient communication and shared decisionmaking that can ultimately lead to a reduction in symptom
intensity and distress [9]. However, one must be careful as
patient-centered scoring systems often classify patients as
either asymptomatic or symptomatic and often only report
nausea, vomiting, or retching and rarely report the combination of the three.
To our knowledge, there have been no studies using a
validated patient-centered nausea and vomiting index to
study PONV in the bariatric surgery patient population. In
this study, we used the validated Rhodes Index of Nausea,
Vomiting, and Retching (RINVR) [10], an 8-item questionnaire, to measure the incidence and severity of nausea, vomiting, and retching. The first iteration (INV) was created by
Rhodes et al. in 1984 [6], with the goal to capture the multidimensional features of upper gastrointestinal suffering.
This earlier iteration evolved to the current format with 5
possible numeric responses, the RINVR. This RINVR was
further validated by Rhodes and McDaniel with high rates
of agreement between the INV-2 and RINVR [6]. Ultimately, the RINVR was chosen for the present study as it
has been validated in the postoperative surgical patient
and can independently assess subjective and objective factors of nausea, vomiting, and retching in both a simple
and reliable fashion, yet still focuses on self-reported patient
symptoms [11].
The objective of the present study is 3-fold. First, our primary aim was to use the RINVR to measure the severity of
PONV after bariatric surgery. Second, we sought to directly
compare the severity of nausea, vomiting, and retching between patients who underwent LSG and LRYGB. Last, we
sought to use these data to identify risk factors for the development of PONV after bariatric surgery. If we could identify
time periods and risk factors for patients who are most
affected by upper gastrointestinal suffering, we can begin
to target therapeutic interventions for this patient population
and reduce the number of postoperative readmissions and
patient suffering.
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Methods
The Washington University Weight Loss Surgery
(WUWLS) team performed a prospective, cross-sectional
study surveying patients postoperatively from January
2017 to December 2018. Based on the team’s standard clinical practice pattern, Rhodes scores were collected at specific time points as follows: postoperative day (POD) 0,
POD 1, POD 2, POD 3 to 4, postoperative clinic visit
(POV) 1 and POV 2. During the patient’s inpatient stay, a
member of the surgical team (nurse practitioner, resident
surgeon, or attending surgeon) would review each question
with the patient and record their answer in a secure database.
On the patient’s follow-up visit, the questionnaire was
completed with the help of a trained medical assistant, registered nurse, or nurse practitioner at the WUWLS clinic.
Based on the final distribution of Rhodes questionnaires
collected, POV 1 was defined to include observation data
points from POD 5 to 25 and POV 2 was defined to include
observation data points from POD 25 to 60. The Washington
University institutional review board (IRB) approved the
project.
Our study inclusion criteria included all patients undergoing primary LSG and LRYGB during the study period. Patients who underwent revisional surgery (i.e., conversion of
LSG to LRYGB, conversion of gastric band to LRYGB, or
revisional LSG or LRYGB) or primary bariatric surgery
other than LRYGB or LSG (i.e., biliopancreatic diversion
or gastric banding) were excluded from the present study.
All patients in the study had operations performed by 1 of
3 fellowship-trained bariatric surgeons. All patients who underwent primary LSG or LRYGB were asked to respond to
the Rhodes questionnaire each day they were in the hospital
and during their first and second postoperative clinic visits.
The data were collected and accumulated in the Health
Insurance Portability and Accountability Act of 1996–
compliant database, RedCap (RedCap 7.3.5, 2019; Vanderbilt University, Nashville, TN, USA).
All surgeries were completed at 1 of 2 hospitals with anesthesiologists that work with bariatric surgeons regularly
and use consistent anesthetic induction strategies between
cases. No preoperative antinausea or pain relief medications
were used. Patients were induced with propofol and inhaled
anesthetics were used for maintenance. Narcotics, most
commonly fentanyl, were used intraoperatively for pain control at the discretion of the anesthesia team. Opioid adjuncts,
including, but not limited to, acetaminophen, dexmedetomidine, ketamine, and gabapentin, were used in a limited
fashion by the anesthesia team preoperatively and intraoperatively. All patients were placed on the same postoperative
pain pathway, which included the use of a hydromorphone
patient-controlled analgesia pump on POD 0 and 1 and
oral narcotics (hydrocodone with acetaminophen or oxycodone with acetaminophen) on POD 2. Postoperative nausea
was treated similarly among all patients as follows: 1
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surgeon placed patients on standing ondansetron every 4
hours, while the other 2 surgeons offered ondansetron every
4 hours as needed. If PONV persisted, prochlorperazine sulfate and transdermal scopolamine were used as adjunctive
agents.
The previously validated RINVR was used. The items in
the questionnaire are shown in Table 1. At each timepoint, a
total Rhodes score was calculated from the sum of the 8
RINVR questions. Total Rhodes scores were compared at
6 different timepoints as well as overall across all 6 time
points, both in aggregate to look at trends over time and
separately to compare LSG versus LRYGB. Patient demographic characteristics and perioperative clinical data
collection, which were associated with the Rhodes scores,
was done via the American Society for Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database. Clinical data included the patient’s
demographic features, such as age, sex, and preoperative
body mass index (BMI), the patient’s main co-morbidities
(gastroesophageal reflux disease, type 2 diabetes, smoking
status, previous steroid use, history of previous surgery),
and perioperative/operative factors, including American Society of Anesthesiologists class, drain placement, operative
time, and length of inpatient stay.
Descriptive statistics on patient characteristics were separately generated for the 2 procedures (LSG and LRYGB),
including mean and standard deviation (SD) for continuous
characteristics and count for categoric characteristics. Two
sample t test and X2 test were used to compare continuous
and categoric characteristics between the 2 procedures.
Linear mixed-effects model for repeated measures was
applied to analyze the Rhodes scores for effect of procedure, changes over time, and their interaction. Least square
mean (LSM) was estimated for each procedure at each
timepoint, as well as the Least Square Estimate (LSE) difference between the 2 procedures at each period with 95%
confidence interval. Multiple comparisons were corrected
for using Tukey-Kramer adjustment. Similar linear mixedeffects model for repeated-measures models are applied to
identify the effect of each preoperative factor for the Rhodes scores accounting for timepoint and the interaction between the preoperative factor and the timepoint. Statistical
significance was set at P , .05.
Results
A total of 309 patients completed 738 Rhodes questionnaires from January 2017 to December 2018. Of 309 patients who completed Rhodes questionnaires, 274 patients
met study criteria and were included for analysis. From
the patients who met study criteria, a total of 605 Rhodes
questionnaires were completed as follows: 250 Rhodes
questionnaires were completed by patients who underwent
LSG, and 355 questionnaires were completed by patients
who had a LRYGB. Of the total 274 patients included in
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Table 1
Rhodes Index of Nausea and Vomiting
Scores

0

1

2

3

4

In the last 12 hr, I threw up __ times
In the last 12 hr, from retching and dry
heaves, I have felt __ distress
In the last 12 hr, from vomiting or throwing
up, I have felt __ distress
In the last 12 hr, I have felt nauseated or sick
to my stomach __ times
In the last 12 hr, from nausea/sickness to my
stomach, I have felt __ distress
In the last 12 hr, each time I threw up, I
produced a __ amount
In the last 12 hr, I have felt nauseated or sick
to my stomach __ times
In the last 12 hr, I have had periods of
retching/dry heaves without bringing
anything up __ times

I did not throw up
No

1–2
Mild

3–4
Moderate

5–6
Great

7
Severe

No

Mild

Moderate

Great

Severe

Not at all

1 hr

2–3 hr

4–6 hr

6 hr

No

Mild

Moderate

Great

Severe

I did not throw up

Small

Moderate

Large

Very large

No

1–2

3–4

5–6

7

No

1–2

3–4

5–6

7

the study, 112 patients underwent an LSG (40.8%). Patient
demographic characteristics for each procedure group
were similar except for preoperative rates of hyperlipidemia
Table 2
Baseline characteristics of bariatric surgery population
Baseline characteristic
variable

Sleeve gastrectomy Gastric bypass P value
(n 5 112)
(n 5 162)

Age
Sex (%)
Male
Female
BMI
Previous surgery (%)
Yes
No
Diabetes (%)
Yes
No
Smoker (%)
Yes
No
COPD
Yes
No
Obstructive sleep apnea (%)
Yes
No
GERD (%)
Yes
No
Hyperlipidemia (%)
Yes
No
History of DVT (%)
Yes
No

44.2 6 11.0

44.8 6 12.0

16 (14.3)
96 (85.7)
49.2 6 10.4

31 (19.1)
131 (80.9)
49.8 6 10.0

4 (3.6)
108 (96.4)

8 (4.9)
154 (95.1)

24 (22.9)
81 (77.1)

26 (18.4)
115 (81.6)

7 (6.3)
105 (93.7)

10 (6.2)
152 (93.8)

5 (4.5)
107 (95.5)

9 (5.6)
153 (94.4)

.5958
.2951

.645
.7666

.3944

.9792

46 (41.1)
66 (58.9)

.6867

Table 3
Perioperative characteristics of bariatric surgery population

.1748

Perioperative characteristic Sleeve gastrectomy Gastric bypass P value
(n 5 112)
(n 5 162)

80 (49.4)
82 (50.6)
.1947

35 (31.3)
77 (68.7)

63 (38.9)
99 (61.1)
.0448*

23 (20.5)
89 (79.5)

51 (31.5)
111 (68.5)
.6487

10 (8.9)
102 (91.1)

with higher preoperative hyperlipidemia rates in LRYGB
patients (P 5 .0448). Perioperative characteristics were
similar between procedures except for operative times,
which, as expected, were statistically longer in the LRYGB
population (P , .0001). Patient demographic characteristics
are presented in Table 2, and perioperative characteristics
are presented in Table 3.
The mean total Rhodes score for LSG is 5.45 (SD, 6.27)
and for LRYGB is 3.08 (SD, 4.19). Overall, total Rhodes
scores are statistically higher in the LSG group compared
with the LRYGB group (F value 5 14.74, P 5 .0002).
When looking at specific timepoints where Rhodes scores
were gathered, there is a statistically significant difference
between the 2 procedures at the earlier visits as follows:
POD 0 (LSG 5 6.96 6 6.50; LRYGB 5 2.89 6 2.90,
P 5 .0115), POD 1 (LSG 5 8.20 6 6.76; LRYGB 5 2.88
6 3.44, P , .0001), and POD 2 (LSG 5 4.05 6 4.88;
LRYGB 5 2.06 6 3.43, P 5 .05). There was no significant

12 (7.4)
150 (92.6)

BMI 5 body mass index; COPD 5 chronic obstructive pulmonary disease; GERD 5 gastrointestinal reflux disease; DVT 5 deep venous
thrombosis.
Age and BMI are reported as a mean 6 standard deviation.
* P  .05.

Steroid Use
Yes
No
ASA classification (%)
Class 2
Class 3
Class 4
Drain placement (%)
Yes
No
Operative time
LOS

.7771
6 (5.4)
106 (94.6)

10 (6.2)
152 (93.8)

39 (34.8)
68 (60.7)
5 (4.5)

39 (24.1)
117 (72.2)
6 (3.7)

3 (2.7)
109 (97.3)
96.7 (26.2)
2.45 (2.1)

5 (3.1)
157 (96.9)
180 (54.8)
2.38 (.8)

.130

.8437

,.0001*
.4455

ASA 5 American Society of Anesthesiologist; LOS 5 length of stay.
Operative time and LOS are reported as mean 6 standard deviation.
* P  .05.
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Fig. 1. This figure compares Rhodes scores between SG and RYGB at the
six specific time points. There was a statistically significant difference in
Rhodes scores between the two procedures at the earlier visits: POD
0 (P 5 .0115), POD 1 (P , .0001) and POD 2 (P 5 .05). There was no
significant difference in Rhodes scores at the other time points (POD 3-4,
P 5 .082; POD 5-25, P 5 .0563; POD 25-60, P 5 .39). Blue line represents
Rhodes scores for SG and red line displays Rhodes scores for RYGB.
*Signifies P  .05. Number of Rhodes questionnaires completed at specific
visits: POD 0 (26 SG; 37 RYGB), POD 1 (59 SG; 82 RYGB), POD 2 (43 SG;
53 RYGB), POD 3-4 (10 SG; 13 RYGB), POD 5-25 (67 SG; 103 RYGB),
POD 25-60 (45 SG; 67 RYGB).

difference in Rhodes scores by procedure at the other timepoints as follows: POD 3 to 4 (LSG 5 2.90 6 4.68; LRYGB
5 2.85 6 2.58, P 5 .082), POD 5 to 25 (LSG 5 3.85 6
4.23; LRYGB 5 2.55 6 3.49, P 5 .0563), and POD 25 to
60 (LSG 5 5.84 1/- 8.12; LRYGB 5 5.07, SD 6 6.36,
P 5 .39) (Fig. 1 and Table 4). Analysis of total Rhodes
scores by percentile also revealed a substantial difference
between the 2 procedures on POD 1 as follows: the total
Rhodes score for the 75th percentile for LSG patients was
13.00 compared with 5.00 for LRYGB patients. For the
95th percentile, a difference of 13 points existed between
the 2 procedures (LSG: 22.00; LRYGB: 9.00) (Tables 5
and 6). Patients who do suffer from nausea, vomiting, and
retching early in their postoperative course tend to
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experience a greater severity of these symptoms after an
LSG compared with LRYGB.
For patients who underwent LSG, there were significantly
higher Rhodes scores on POD 0 and 1 compared with POD 5
to 25 (t value 5 1.97, LSM 5 2.17, standard error [SE] 5
1.20, P 5 .049 and t value 5 4.79, LSM 5 4.07, SE 5
.84, P , .0001, respectively) as well as a significantly higher
Rhodes scores at POD 25 to 60 compared with POD 5 to 25
(t value 5 2.17, LSM 5 1.97, SE 5 .91, P 5 .03). Additionally, there was significantly higher Rhodes scores on POD 1
compared with POD 25 to 60 (t value 5 2.22, LSM 5 2.09,
SE 5 .94, P 5 .03) and no difference in Rhodes scores between POD 0 and POD 25 to 60 (t value 5 .17, LSM 5 .20,
SE 5 1.17, P 5 .87) (Table 7). Among the patients who had
a RYGB, patients had statistically higher Rhodes scores on
POD 25 to 60 compared with POD 0, POD 1, POD 2, and
POD 5 to 25 (t value 5 2.23, LSM 5 2.17, SE 5 .97,
P 5 .026; t value 5 2.8, LSM 5 2.20, SE 5 .78, P 5 .005;
t value 5 3.55, LSM 5 23.10, SE 5 .87, P 5 .0004; t value
5 3.6, LSM 5 2.65, SE 5 .74, P 5 .0003, respectively)
(Table 7). Thus, for those who underwent LSG, scores were
highest on POD 0 and 1 with a second peak at POD 25 to
60. Those who underwent LRYGB experienced the most
symptoms of nausea, vomiting, and retching around POD
25 to 60.
The only preoperative risk factor independently associated with increased Rhodes scores (Table 8) was female
sex. Across all timepoints, total Rhodes scores were statistically higher in female patients compared with male patients
(female: 4.43 6 5.46; male: 2.35 6 3.90, P 5 .021). The difference in Rhodes score by sex was most pronounced at
POV 2 (female patients experience more gastrointestinal
suffering at POV 2 compared with their male counterparts)
(female: 6.12 6 7.56; male: 2.19 6 3.09, P 5 .0008). Age,
preoperative BMI, gastroesophageal reflux disease, type 2
diabetes, smoking, previous steroid use, and history of previous surgery were not independently associated with higher
Rhodes scores (Table 8). The only perioperative characteristic that was independently associated with a higher Rhodes
score was a shorter length of surgery (LSG: 96.7 6 26.2
min; LRYGB: 180 6 54.48 min; P , .0001). Preoperative

Table 4
Comparing sleeve gastrectomy to gastric bypass total Rhodes scores
Postoperative time
period (POD)

LSM estimate
difference (SG-RYGB)

Standard
error

95%CI lower
limit

95%CI upper
limit

t value

P value

POD 0
POD 1
POD 2
POD 3–4
POD 5–25
POD 25–60

3.17
5.09
1.96
.46
1.48
.80

1.25
.84
1.00
2.07
.77
.95

5.62
6.75
3.93
4.53
3.00
2.66

.72
3.43
2.01
23.60
2.04
21.06

2.54
6.03
1.95
.22
1.91
.84

.01*
,.0001*
.05*
.82
.06
.40

POD 5 postoperative day; LSM 5 least square mean; SG 5 sleeve gastrectomy; RYGB 5 Roux-en-Y gastric bypass; CI 5 confidence interval.
Scores are the differences of the least square mean estimates between procedures during the postoperative time period.
* P  .05.
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Table 5
Mean Rhodes score by percentile and by sleeve gastrectomy
Visit

# Questionnaires

Mean

SD

10th

25th

50th

75th

95th

POD 0
POD 1
POD 2
POD 3–4
POD 5–25
POD 25–60

26
59
43
10
67
45

5.96
8.20
4.05
2.90
3.85
5.84

6.50
6.76
4.88
4.68
4.23
8.12

.00
.00
.00
.00
.00
.00

.00
2.00
.00
.00
.00
.00

4.50
7.00
2.00
1.00
2.00
3.00

7.00
13.00
6.00
2.00
6.00
7.00

21.00
22.00
14.00
13.00
11.00
22.00

POD 5 postoperative day.
10th, 25th, 50th, 75th, and 95th refer to the 10th, 25th, 50th, 75th, and 95th percentile,
respectively.

compared with LRYGB. Additionally, patients experienced
peak symptoms either early on after surgery (POD 0, 1, and
2) or around the time of POV 2 (days 25–60). Those who
had an LSG were more likely to be symptomatic in the early
postoperative period and on POV 2, while those who underwent LRYGB were more likely to be symptomatic around
the time of POV 2. Last, overall, female sex was an independent risk factor for PONV. This sex discrepancy was most
pronounced among those who underwent LRYGB. To
date, this is the largest systematic study of a validated
PONV score in bariatric patients to objectively measure
nausea, vomiting, and retching after bariatric surgery.
Overall Rhodes scores were significantly higher in LSG
patients compared with LRYGB patients suggesting greater
rates of PONV in this group. This effect was most pronounced in the early postoperative time period (POD 0–2:
inpatient stay), and the differences between the 2 groups
were smaller at the time of follow-up visits. Previous studies
comparing rates of PONV after LSG and LRYGB are mixed.
A recent study published by Celio et al. [4], prospectively
examining a cohort of 65 patients, found no difference in
early PONV between the 2 groups. Although this group
used a patient-centered scoring tool, the tool had not been
previously validated in a postoperative surgical patient population like the Rhodes score [6]. Other groups have found
LSG patients struggle with PONV early in their postoperative course. For instance, Major et al. [12] found a significantly greater rate of PONV in LSG patients compared
with LRYGB and an increased need for intravenous fluids

American Society of Anesthesiologists class and length of
inpatient stay were not associated with higher Rhodes scores
(Table 8). On subset analysis (i.e., analyzing perioperative
risk factors independently for LSG and LRYGB), we found
no statistical association in total Rhodes scores with length
of inpatient stay, operative time, or American Society of Anesthesiologists class for either the LSG or LRYGB. However, female patients who underwent LRYGB had statistically
higher total Rhodes scores over all time periods compared
with males (female: 3.37 6 4.38; male: 1.89 6 3.09, P 5
.0266). While there was trend to higher Rhodes scores in females who underwent LSG, this difference was ultimately
not statistically significant (female: 5.79 6 6.37; male:
3.29 6 5.11, P 5 .1526).
Discussion
Evaluation of PONV continues to remain a crucial, yet
challenging issue after bariatric surgery, and complications
secondary to PONV are the most common cause for readmission in the first 30 postoperative days. Nevertheless,
few studies have examined the rates of PONV between
the 2 most common bariatric procedures performed in the
United States. The objective of the present study was to
use a patient-centered, validated nausea, vomiting, and
retching questionnaire to compare PONV in the 2 most
commonly performed bariatric surgeries. The findings of
the present study were 3-fold. PONV, as determined by Rhodes scores, was greater in patients who underwent LSG

Table 6
Mean Rhodes score by percentile and by Roux-en-Y gastric bypass
Visit

# Questionnaires

Mean

SD

10th

25th

50th

75th

95th

POD 0
POD 1
POD 2
POD 3–4
POD 5–25
POD 25–60

37
82
53
13
103
67

2.89
2.88
2.06
2.85
2.55
5.07

2.90
3.44
3.43
2.58
3.49
6.36

.00
.00
.00
.00
.00
.00

.00
.00
.00
.00
.00
.00

4.00
2.00
.00
3.00
1.00
4.00

5.00
5.00
3.00
5.00
4.00
6.00

8.00
9.00
8.00
8.00
10.00
16.00

POD 5 postoperative day.
10th, 25th, 50th, 75th, and 95th refer to the 10th, 25th, 50th, 75th, and 95th percentile,
respectively.
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in the first 24 hours postoperatively [12]. We hypothesize
this may be related to the physiology of the LSG as the
LSG is associated with increased intragastric pressure,
decreased lower esophageal sphincter pressure, and
increased esophageal acid exposure [13,14]. Further studies
are needed to correlate these physiologic findings with
PONV.
For both LSG and LRYGB patients, a PONV peak
occurred around the second postoperative visit (w5–6 wk
postoperatively). Prior researchers have examined early
PONV. For example, Halliday et al. [3] found PONV was
worse in the first 24 hours and slowly improved over the
next 4 days. However, few studies have examined nausea,
vomiting, and retching past the initial inpatient hospital
stay with most data analysis culminating at 30 days. Interestingly, our data suggest these symptoms recur as a significant problem 1 to 2 months after surgery in patients
undergoing both LSG and LRYGB, which requires further
research attention. It is possible that as patients begin their
diet advancement and begin to experiment with food, they
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may overestimate their capabilities or revert to old habits
with the consumption of heavy meals. This may also be
the time when patients develop stomal stenosis or sleeve stenosis relating to postoperative edema and healing. This second observed nausea, vomiting, and retching peak shows the
importance of frequent, close follow-up with patients and
continued education and support.
Female sex was associated with statistically higher Rhodes scores suggesting increased PONV in female patients after bariatric surgery. Apfel et al. [15] were the first to
identify female sex as a risk factor for nausea and vomiting
in the bariatric surgery population. Although the reason
behind this effect remains unclear, being able to target atrisk patients (females) can help ensure the return of key
postoperative bariatric functions, oral fluid intake, protein
intake, and exercise while guaranteeing an early, safe
discharge [12]. Interestingly, on subgroup analysis, the sex
discrepancy was most pronounced in the LRYGB population, with higher Rhodes scores in female patients across
all 6 timepoints (although the difference was only

Table 7
Comparing Rhodes scores at different postoperative time periods for both SG and RYGB
POD
POD 0 versus POD 1
POD 0 versus POD 2
POD 0 versus POD 3–4
POD 0 versus POD 5–25
POD 0 versus POD 25–60
POD 1 versus POD 2
POD 1 versus POD 3–4
POD 1 versus POD 5–25
POD 1 versus POD 25–60
POD 2 versus POD 3–4
POD 2 versus POD 5–25
POD 2 versus POD 25–60
POD 3–4 versus POD 5–25
POD 25–60 versus POD 3–4
POD 25–60 versus POD 5–25
POD 0 versus POD 1
POD 0 versus POD 2
POD 0 versus POD 3–4
POD 0 versus POD 5–25
POD 0 versus POD 25–60
POD 1 versus POD 2
POD 1 versus POD 3–4
POD 1 versus POD 5–25
POD 1 versus POD 25–60
POD 2 versus POD 3–4
POD 2 versus POD 5–25
POD 2 versus POD 25–60
POD 3–4 versus POD 5–25
POD 25–60 versus POD 3–4
POD 25–60 versus POD 5–25

LSM estimate difference
Sleeve gastrectomy
21.89
2.14
3.07
2.17
.20
4.04
4.97
4.07
2.09
.93
.03
21.94
2.90
2.88
1.97
Gastric bypass
.03
.93
.37
.48
22.17
.90
.34
.45
22.20
2.56
2.45
23.10
.11
2.54
2.65

Standard error

95%CI lower limit

95%CI upper limit

t value

P value

1.10
1.16
1.79
1.10
1.17
.92
1.65
.84
.94
1.69
.93
1.01
1.64
1.68
.91

24.06
2.14
2.43
.002
22.11
2.22
1.72
2.40
.24
22.39
21.79
23.92
24.13
2.42
.19

.28
4.42
6.59
4.34
2.50
5.85
8.22
5.73
3.94
4.26
1.85
.04
2.33
6.17
3.76

21.72
1.85
1.72
1.97
.17
4.37
3.00
4.79
2.22
.55
.03
21.93
2.55
1.72
2.17

.09
.07
.09
.05*
.87
,.01*
.01*
,.01*
.03*
.58
.97
.05*
.58
.09
.03*

.93
1.01
1.56
.91
.97
.81
1.45
.70
.78
1.50
.80
.87
1.44
1.48
.74

21.79
21.05
22.70
21.31
24.08
2.69
22.51
2.92
23.74
23.50
22.02
24.82
22.72
2.37
1.21

1.85
2.92
3.43
2.27
2.26
2.50
3.20
1.83
2.66
2.38
1.12
21.39
2.94
5.45
4.10

.03
.92
.24
.53
22.23
1.12
.24
.65
22.80
2.38
2.56
23.55
.08
1.71
3.60

.98
.36
.81
.60
.03*
.26
.81
.52
,.01*
.71
.57
.01*
.94
.08
,.01*

SG 5 sleeve gastrectomy; RYGB 5 Roux-en-Y gastric bypass; POD 5 postoperative day; LSM 5 least square mean; CI 5 confidence interval.
Scores are the differences of the least square mean estimates between postoperative time periods for each procedure.
* P  .05.
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Table 8
Preoperative and perioperative risk factors associated with higher Rhodes
scores
Independent variable

F value

P value

Female sex
Age
Preoperative BMI
GERD
Type 2 diabetes
Smoking
Previous steroid use
History of previous surgery
ASA class
Length of inpatient stay
Operative time

5.38
2.44
.68
1.49
.08
1.03
.03
.02
.12
.86
7.59

.02*
.12
.41
.22
.77
.31
.87
.88
.88
.35
,.01*

BMI 5 body mass index; GERD 5 gastroesophageal reflux disease;
ASA 5 American Society of Anesthesiology.
* P  .05.

statistically significant at POV 2). Although this trend was
also found in the SG patients, this difference between men
and women’s scores was not statistically significant. The
finding that PONV has a greater sex discrepancy in the
LRYGB compared with LSG is a new finding and should
be explored in future research.
Although total Rhodes scores for LSG (5.45) and for
LRYGB (3.08) are statistically significantly different,
defining whether this difference is clinically significant is
more challenging. If one were to review the RINVR questionnaire (Table 1), we see that the difference in total Rhodes scores (2.37) between LSG and LRYGB patients
roughly correlate to that of each LSG patient answering a
point higher on 2 to 3 of the total 8 questions. For example,
instead of vomiting “1 to 2” times in the last 12 hours, a SG
patient may report vomiting “3 to 4” times. Alternatively,
instead of feeling “nauseated” ,1 hour in the last 12 hours,
he or she felt nauseated for 2 to 3 hours. To the authors, this
finding is clinically significant. Alternatively, if one were to
examine the Rhodes scores quartile data, there is a marked
difference in total Rhodes scores between the 2 groups. The
Rhodes score for the 75th percentile on POD 1 for LSG patients was 13.00 compared with 5.00 for LRYGB patients.
This difference of 8 points translates, on average, to each
LSG patient rating their suffering 1 point higher on each
question of the RINVR questionnaire. Furthermore, the
sickest LSG patients are suffering more intensely than the
sickest LRYGB patients. There is a large difference on
POD 1 between the 2 procedures for the 95th percentile
(mean Rhodes score: LSG, 22.00 versus RYGB, 9.00) and
this difference is certainly clinically meaningful.
It remains clear that PONV remains a challenging and
frequent problem after bariatric surgery. In response to our
findings, the WUWLS team has implemented a multimodal
pain and nausea pathway to attempt to reduce PONV.
Because of the data described in this study, WUWLS is pretreating all bariatric surgery patients with a scopolamine
patch and oral aprepitant, counseling at risk patients

(females and LSG) preoperatively for signs and symptoms
of postoperative dehydration, and providing prophylactic
nonopioid analgesic medications preoperatively in the holding area (acetaminophen, gabapentin, and celecoxib) in
attempt to cut down on postoperative opioid use, which
may exacerbate PONV. Intraoperatively, we have worked
with the anesthesia team to decrease use of opioids by
increasing use of nonopioid medications, such as ketamine
and magnesium intravenously. Postoperatively, we have discontinued the routine use of a patient-controlled analgesia
on POD 0 and 1, instituted a standardized multimodal
approach for pain control (acetaminophen, celecoxib, cyclobenzaprine, hyoscyamine, and breakthrough oxycodone if
needed) and nausea (continued transdermal scopolamine,
scheduled ondansetron, and breakthrough prochlorperazine). At discharge, our team is contacting high-risk patients
regularly and scheduling follow-up clinic visits more
frequently, especially between POV 1 to 2 timeframe, to better identify patients who may be struggling with late PONV
and may be at risk for readmission for intravenous nutrition
and hydration. The findings of the present study have led to
meaningful changes in the perioperative care of patients undergoing bariatric surgery at WUWLS to decrease PONV.
There are several other future directions that should be
addressed. While the Rhodes score has been validated and
remains short at only 8 questions, it can remain challenging
for patients to complete, especially in the immediate postoperative recovery period. Ideally, a shorter validated nausea,
vomiting, and retching questionnaire that could quantify patient symptoms and directly target bariatric specific factors
should be created. Additionally, while the present study is
1 of only a few that examined PONV extending to even
the second postoperative visit, further work should be
done to better map out this second peak in nausea, vomiting,
and retching. It is possible targeted, short, and frequent patient education sessions or follow-up in the first 3 months
postoperatively could help to manage these symptoms.
A potential limitation of our study was that not all patients completed the same number of Rhodes questionnaires
and the timepoints at which they were completed, especially
during clinic visits, were not always consistent. The authors
attempted to correct for this by plotting a frequency graph
and using this to determine timepoints that made clinical
sense in our practice.
Conclusions
To date, this is the largest study using a validated questionnaire, the RINVR, to objectively measure PONV after
bariatric surgery. The factors found to be most associated
with PONV were SG and female sex. For patients undergoing LSG, we found that there appeared to be the following
2 PONV peaks: the immediate postoperative inpatient stay
(POD 0–2) and the second follow-up visit. Patients who underwent a RYGB had significantly worse PONV on their
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second POV. Sex discrepancy of PONV was most pronounced in RYGB patients. These data may help bariatric
surgery programs, including WUWLS, identify and counsel
patients who may require more intensive treatment of
PONV, particularly POD 0, POD 1, and in the later surgical
recovery phase.
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